Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering
BackgroundThe advent of biologics has significantly transformed treatment strategies for neuromyelitis optica spectrum disorder (NMOSD). However, there are no biomarkers that predict relapses associated with steroid tapering; therefore, it is critical to identify potential indicators of disease acti...
Saved in:
Main Authors: | Ryohei Yamamura, Makoto Kinoshita, Yoshiaki Yasumizu, Tomohiro Yata, Keigo Kihara, Daisuke Motooka, Naoyuki Shiraishi, Yasuko Sugiyama, Shohei Beppu, Hisashi Murata, Naoshi Koizumi, Itsuki Sano, Toru Koda, Tatsusada Okuno, Hideki Mochizuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1508977/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuromyelitis optica spectrum disorder: epidemiology, pathogenesis, diagnosis, treatment, and prognosis
by: J. Čemerkaitė, et al.
Published: (2021-03-01) -
Hemorrhagic Longitudinally Extensive Transverse Myelitis (LETM) as a First Presentation of Neuromyelitis Optica Spectrum Disorder (NMOSD): A Case Report and Literature Review
by: Shima Jahani, et al.
Published: (2025-01-01) -
Acute Respiratory Failure due to Neuromyelitis Optica Treated Successfully with Plasmapheresis
by: Massa Zantah, et al.
Published: (2016-01-01) -
Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
by: Jean-Baptiste Chanson, et al.
Published: (2013-01-01) -
The Big Yawning: Pathological Yawning as a Symptom of Neuromyelitis Optica Spectrum Disorders
by: Veronika Spahlinger, et al.
Published: (2019-01-01)